Wall Street brokerages expect Polarityte Inc (NASDAQ:PTE) to report sales of $1.40 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Polarityte’s earnings, with the lowest sales estimate coming in at $1.00 million and the highest estimate coming in at $1.80 million. Polarityte posted sales of $10,000.00 in the same quarter last year, which would indicate a positive year-over-year growth rate of 13,900%. The firm is expected to issue its next earnings results on Monday, April 15th.

According to Zacks, analysts expect that Polarityte will report full-year sales of $15.34 million for the current fiscal year, with estimates ranging from $8.40 million to $20.00 million. For the next year, analysts forecast that the business will post sales of $44.57 million, with estimates ranging from $30.20 million to $55.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for Polarityte.

Polarityte (NASDAQ:PTE) last released its quarterly earnings data on Monday, January 14th. The company reported ($0.96) EPS for the quarter, topping the Zacks’ consensus estimate of ($1.02) by $0.06. Polarityte had a negative net margin of 4,259.44% and a negative return on equity of 258.52%. The firm had revenue of $1.13 million during the quarter, compared to analysts’ expectations of $0.80 million.

A number of research firms have commented on PTE. Zacks Investment Research cut shares of Polarityte from a “hold” rating to a “sell” rating in a research report on Friday, February 1st. National Securities began coverage on shares of Polarityte in a research report on Monday, January 28th. They set a “sell” rating and a $5.00 price objective for the company. ValuEngine cut shares of Polarityte from a “buy” rating to a “hold” rating in a research report on Tuesday, February 5th. Oppenheimer began coverage on shares of Polarityte in a research report on Tuesday, January 29th. They set an “outperform” rating and a $30.00 price objective for the company. Finally, Northland Securities began coverage on shares of Polarityte in a research report on Monday, January 28th. They set an “outperform” rating and a $50.00 price objective for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company. Polarityte currently has an average rating of “Buy” and an average target price of $34.33.

PTE stock traded down $0.20 during midday trading on Wednesday, reaching $8.61. 424,600 shares of the company were exchanged, compared to its average volume of 345,313. The company has a debt-to-equity ratio of 0.01, a current ratio of 13.80 and a quick ratio of 13.76. Polarityte has a one year low of $8.46 and a one year high of $41.22. The stock has a market cap of $190.74 million, a price-to-earnings ratio of -1.77 and a beta of 1.48.

An institutional investor recently bought a new position in Polarityte stock. Comprehensive Portfolio Management LLC bought a new stake in Polarityte Inc (NASDAQ:PTE) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 21,702 shares of the company’s stock, valued at approximately $232,000. Comprehensive Portfolio Management LLC owned 0.10% of Polarityte as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 54.85% of the company’s stock.

Polarityte Company Profile

PolarityTE, Inc, a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services.

Further Reading: How to Use the New Google Finance Tool

Get a free copy of the Zacks research report on Polarityte (PTE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Polarityte (NASDAQ:PTE)

Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.